Researchers investigate why aspirin fails some moms at risk of dangerous pregnancy condition
NCT ID NCT05709483
Summary
This study aims to understand why low-dose aspirin, a common preventive treatment, sometimes fails to stop preeclampsia from recurring in high-risk pregnancies. Researchers will enroll 130 women with a history of preeclampsia who took aspirin in a later pregnancy. They will compare blood samples and genetic information between women who had another episode of preeclampsia and those who did not, focusing on a specific gene variant that may affect how aspirin works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rockefeller University
RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.